FDA clears migraine device for children as young as 8
A device long used by adults to manage migraines was now available for children as young as eight years old, offering new ...
FDA approves Symbravo for acute treatment of migraine in adults
The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...
Hosted on MSN1d
FDA Has Approved A New Medication Treatment For Migraines In Adults
Many people use the terms ‘migraine’ and ‘headache’ interchangeably. This leads many people to believe that migraines are not ...
TMJ42d
Answering Headache Questions – PLUS a New Clinical Trial for Migraine
Mind+ Neurology is advancing medical research and offering hope to patients living with migraine. Aaron Hart & Kelly Reynolds ...
MedPage Today2d
New Migraine Prevention Guideline Strays From Expert Recommendations
The ACP guideline, published in Annals of Internal Medicine, includes three recommendations centered around monotherapy: ...
Healio3d
ACP releases clinical guidelines for preventing episodic migraines
The ACP issued new clinical guidance on preventing episodic migraines, classified as one to 14 headache days per month, in ...
KamCity4d
Panadol Launches New Sub-Brand Offering Migraine Relief
Panadol is launching a new sub-brand called Panmigrol. It includes two variants – Panmigrol Migraine and Headache Relief coated tablets (acetylsalicylic acid, paracetamol, caffeine) in the grocery ...